USA TODAY - Alcoholics cut heavy drinking when taking drug off-label
January 11th, 2009A drug sold to prevent seizures and migraines was more effective than a placebo in reducing alcoholics’ heavy-drinking days, a study says.
Unlike other drugs to treat alcoholism, topiramate, or Topamax, does not require people to stop drinking before starting treatment, the study’s authors write in today’s Journal of the American Medical Association.
In addition, treatment required a weekly 15-minute counseling session, done by nurses in the study.
…
Chain Drug Review - Ortho-McNeil, J&J step up the fight against dispensing errors
January 6th, 2009 TITUSVILLE, N.J. — OrthoMcNeil Neurologics Inc. and Johnson & Johnson Pharmaceutical Research & Development LLC are alerting prescribers and other health care professionals to the possibility of dispensing errors involving Topamax, Razadyne ER and Razadyne.
“Dispensing confusion between two drug products with similar brand names…
Chain Drug Review - Top 50 prescription drugs by dollar sales
January 4th, 2009Ton 50 Prescription Drugs by Dollar Sales
DOLLAR % CHANGE
SALES MARKET VS. YEAR
PRODUCT COMPANY (000) SHARE AGO
Lipitor Pfizer $8,100 2.8% -7%
Nexium …
USA TODAY - Epilepsy drug adds birth risk
January 2nd, 2009Pregnant women who take the epilepsy drug topiramate may increase their newborn’s risk of birth defects, especially if they combine the drug with other epilepsy medications, according to a small study in this week’s Neurology.
Scientists who evaluated 203 women who became pregnant while taking topiramate, generic for Topamax, reported that of 178 babies born, 16 had major birth defects, including cleft palate and other …
Oakland Tribune - Migraine pill helps some alcoholics taper off drinking
December 30th, 2008 CHICAGO — A migraine pill seems to help alcoholics taper off their drinking without detox treatment, researchers report, offering a potential option for a hard-to-treat problem.
The drug, Topamax, works in a different way than three other medications already approved for treating alcoholism.
Experts said the drug is likely to appeal to heavy drinkers who would rather seek help from their own doctors, rather than enter a rehab clinic to dry out. The drug costs at least $350 a month…
Internal Medicine News - Topamax/Toprol-XL confusion: a capital offense?
December 28th, 2008 The most effective way to prevent further confusion between Topamax and Toprol-XL–the brand names of topiramate and metoprolol succinate–would be to change one of their names, according to Michael R. Cohen, president of the Institute for Safe Medication Practices.
A complete name change would not be necessary, Mr. Cohen said in an interview; capital letters co…
Chain Drug Review - Topamax receives pediatric exclusivity
December 25th, 2008Related Results
TopamaxTopamax indicationTopamax cleared by FDATopamax approved for new indicationTopamax
> Topamax has been granted pediatric exclusivity from the Food and Drug Administration. The Ortho-McNeil Ne…
Chain Drug Review - Topamax indication
December 21st, 2008The FDA has approved Topamax tablets and sprinkle capsules as an add-on treatment for adults and children who suffer from seizures associated with Lennox-Gastaut Syndrome, a severe, debilitating form of epilepsy. The condition accounts for up to 10% of all cases of pediatric epilepsy.
Related Results
TopamaxTopamax cleared by FDATopamax receives pedia…
Business Wire - NeurAxon Appoints Robert Medve, M.D., as Chief Medical and Regulatory Officer
December 15th, 2008WALTHAM, Mass. — NeurAxon Inc., a developer of next generation pain therapeutics targeting neuronal nitric oxide synthase (nNOS), announced today the appointment of Robert Medve, M.D., to the newly created position of Chief Medical and Regulatory Officer of the Company. Dr. Medve was most recently Vice President of Science, Research and Development of Lifetree Clinical Research, a clinical research organization focused on clini…
Something Can Be Done!
December 12th, 2008Photo Credit: Bill Lloyd, MDHave you felt it?Recently there has been a run of pessimism on our WebMD Vision & Eye Disorders message board. An unusually large percentage of visitors are suffering, worried, frustrated, or all of the above. A common thread running through these messages is exhaustion…everything has been tried and there appears to be little more for their doctors…


